Diagnostic Power of Serum Creatinine/Cystatin C Ratio for Identifying Low MRI-Muscle Volume and Low Grip Strength: Data From 9 731 to 149 707 UK Biobank Older Adults
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 11.12.2024 · 80 (1)
DOI: 10.1093/gerona/glae274 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 14.11.2024. Verfasst von Ben Kirk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Western Health, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Cystatin C, Hand Strength, Creatinine, Sarcopenia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Claude D. Pepper Older American Independence Centers, Future Health Research and Innovation Fund.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Biomarkers for sarcopenia are lacking. We examined the diagnostic power of serum creatinine to cystatin C ratio for identifying low magnetic resonance imaging-muscle volume and low grip strength in a large observational study of UK Biobank older adults.
Methods
Serum creatinine and cystatin C were measured via immunoassays (Beckman Coulter AU5800 and Siemens Advia 1800, respectively) and grip strength by hydraulic hand dynamometer at baseline visit (2008–2010). magnetic resonance imaging-thigh fat-free muscle volume and DXA-derived appendicular lean mass were measured at imaging visit (2014–2018). Extreme outliers were removed, and covariates (demographic, lifestyle, and clinical factors, as well as time elapsed between baseline-imaging visit) were adjusted for in statistical models.
Results
12 873 older adults (mean age: 63.5 ± 2.7 years, 44.2% women) were included for fat-free muscle volume and appendicular lean mass/body mass index; 149 707 older adults (mean age: 64.0 ± 2.9 years, 50.5% women) for grip strength. Despite significant associations (p < .05), in fully adjusted models, creatinine to cystatin C showed poor to acceptable diagnostic power for identifying low fat-free muscle volume when using cutpoints of 20th percentile (area under the curve: 0.577 men; 0.622 women) and T scores of −2 (area under the curve: 0.596 men; 0.659 women) and −2.5 (area under the curve: 0.609 men; 0.722 women). In fully adjusted model, creatinine to cystatin C showed poor diagnostic power (area under the curves: <0.70) for identifying low appendicular lean mass/body mass index or low grip strength, irrespective of the cutpoint used.
Conclusions
Creatinine to cystatin C may not be a suitable biomarker for identifying low muscle volume or low strength in older adults. This finding, drawn from a large sample size and the use of advanced medical imaging, marks an important contribution to the sarcopenia field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Western Health, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
- Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, Melbourne, Victoria, Australia.
- The Cato T. Laurencin Institute for Translation in Regenerative Engineering, University of Connecticut Health, Farmington, Connecticut, USA.
- UConn Center on Aging, University of Connecticut, Farmington, Connecticut, USA.
- Department of Musculoskeletal Biology, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
- Nutrition and Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
ORCID-Profile: Ben Kirk, Chia-Ling Kuo, Jesse Zanker, Konstantinos Prokopidis, Marc Sim, Gustavo Duque
Förderung
- NIA NIH HHS
- Claude D. Pepper Older American Independence Centers
- Future Health Research and Innovation Fund
- Royal Perth Hospital Research Foundation
Zitieren
APA
Kirk, B., Kuo, C. L., Liu, P., Xiang, M., Zanker, J., Prokopidis, K., Sim, M., Fortinsky, R. H., Kuchel, G. A., & Duque, G. (2024). Diagnostic Power of Serum Creatinine/Cystatin C Ratio for Identifying Low MRI-Muscle Volume and Low Grip Strength: Data From 9 731 to 149 707 UK Biobank Older Adults. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 80(1). https://doi.org/10.1093/gerona/glae274
Vancouver
Kirk B, Kuo CL, Liu P, Xiang M, Zanker J, Prokopidis K, et al. Diagnostic Power of Serum Creatinine/Cystatin C Ratio for Identifying Low MRI-Muscle Volume and Low Grip Strength: Data From 9 731 to 149 707 UK Biobank Older Adults. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2024;80(1). doi:10.1093/gerona/glae274
BibTeX
@article{Kirk2024,
author = {Kirk, Ben and Kuo, Chia-Ling and Liu, Peiran and Xiang, Meiruo and Zanker, Jesse and Prokopidis, Konstantinos and Sim, Marc and Fortinsky, Richard H and Kuchel, George A and Duque, Gustavo},
title = {Diagnostic Power of Serum Creatinine/Cystatin C Ratio for Identifying Low MRI-Muscle Volume and Low Grip Strength: Data From 9 731 to 149 707 UK Biobank Older Adults},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2024},
volume = {80},
number = {1},
doi = {10.1093/gerona/glae274}
}
EUVIMED